Zopapogene Imadenovec for the Treatment of Recurrent Respiratory Papillomatosis in Children
Study sponsor: Precigen, Inc · PGEN
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2029-01Estimated
Enrollment · participants15Estimated
Source updated2026-10-28Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.